Growth Metrics

Oruka Therapeutics (ORKA) Tax Provisions (2018 - 2020)

Oruka Therapeutics' quarterly Tax Provisions came in at -$9000.0 in Q2 2020, up 66.67% year-on-year from -$5400.0 in Q3 2019, and up 43.75% quarter-over-quarter from -$16000.0 in Q4 2019.

Oruka Therapeutics has reported Tax Provisions for 3 years, with the latest figure at -$9000.0 in Q2 2020.

  • For the quarter ending Q2 2020, Tax Provisions rose 66.67% year-over-year to -$9000.0; the trailing twelve-month figure through Dec 2020 stood at -$25000.0 (up 85.03% YoY), and the FY2020 full-year result was -$9000.0, up 94.61% from the prior year.
  • Tax Provisions for Q2 2020 stood at -$9000.0, up from -$16000.0 in the prior quarter.
  • The five-year high for Tax Provisions was -$9000.0 in Q2 2020, with the low at -$82000.0 in Q1 2019.
  • Average Tax Provisions over 3 years is -$34500.0, with a median of -$29000.0 recorded in 2018.
  • Year-over-year, Tax Provisions tumbled 35.48% in 2019 and jumped 66.67% in 2020.
  • Tracing ORKA's Tax Provisions over 3 years: stood at -$31000.0 in 2018, then soared by 48.39% to -$16000.0 in 2019, then soared by 43.75% to -$9000.0 in 2020.
  • The last three Tax Provisions figures came in at -$9000.0 (Q2 2020), -$16000.0 (Q4 2019), and -$42000.0 (Q3 2019), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Taxes (Qtr)
1 Quantum Biopharma 961,148.99 Bn 961,148.98 Bn - -
2 Alterity Therapeutics 744,933.29 Bn 744,933.26 Bn - -
3 Legend Biotech 2,540.00 Bn 2,539.71 Bn 242.10 Mn -11.20 Mn
4 Nanobiotix 2,199.85 Bn 2,199.78 Bn - -
5 Akari Therapeutics 1,635.88 Bn 1,635.88 Bn - -859,000.00
6 Vertex Pharmaceuticals 111.32 Bn 104.07 Bn 2.59 Bn 221.50 Mn
7 Evaxion A 62.56 Bn 62.54 Bn - 216,000.00
8 Regeneron Pharmaceuticals 62.55 Bn 53.79 Bn 3.31 Bn 104.00 Mn
9 Alnylam Pharmaceuticals 39.57 Bn 36.56 Bn 959.66 Mn 15.66 Mn
10 Oruka Therapeutics 3.04 Bn 2.65 Bn - -

Historic Data

Download Data 🔒
DateValue
Jun 30, 2020 -9,000.00
Dec 31, 2019 -16,000.00
Sep 30, 2019 -42,000.00
Jun 30, 2019 -27,000.00
Mar 31, 2019 -82,000.00
Sep 30, 2018 -31,000.00